VeriMomIst ginsenoside rh4 in der Schwangerschaft sicher?
No harmonised CLP classification, no SCCS or CIR cosmetic safety assessment specific to ginsenoside Rh4 was found and there are no published reproductive/teratology studies for Rh4; therefore hazard is default 0. However, some ginsenosides show estrogen-related or bioactive signaling effects in vitro and Rh4 shows biological activity in cultured cells and animal models (e.g. anti‑tumor, AMPK, gut/liver signaling), so a theoretical mechanistic concern (structural/class similarity to other ginsenosides) is noted (m=1). Topical cosmetic exposure is expected to give negligible systemic absorption for a large polar triterpenoid glycoside, so exposure is scored e=0 for pregnant adults. Sources: PubMed studies on Rh4 activity, ECHA substance info (no harmonised CLP), EWG ingredient entry.
Related ingredients
Frequently asked questions
- Ist ginsenoside rh4 in der Schwangerschaft sicher?
- No harmonised CLP classification, no SCCS or CIR cosmetic safety assessment specific to ginsenoside Rh4 was found and there are no published reproductive/teratology studies for Rh4; therefore hazard is default 0. However, some ginsenosides show estrogen-related or bioactive signaling effects in vitro and Rh4 shows biological activity in cultured cells and animal models (e.g. anti‑tumor, AMPK, gut/liver signaling), so a theoretical mechanistic concern (structural/class similarity to other ginsenosides) is noted (m=1). Topical cosmetic exposure is expected to give negligible systemic absorption for a large polar triterpenoid glycoside, so exposure is scored e=0 for pregnant adults. Sources: PubMed studies on Rh4 activity, ECHA substance info (no harmonised CLP), EWG ingredient entry.
- Ist ginsenoside rh4 während des Stillens sicher?
- No data showing Rh4 transfers in breastmilk or causes reproductive/lactation toxicity; no regulatory flags (harmonised CLP / SCCS / CIR). Theoretical mechanistic concern retained (m=1) because ginsenosides as a class have bioactivity in vitro and some other ginsenosides have shown estrogen receptor interactions in studies. Expected topical exposure and transfer to milk is low → e=0 for topical use. Relevant data on whole‑ginseng in LactMed highlights general ginseng concerns but does not provide Rh4‑specific breastfeeding data.
- Ist ginsenoside rh4 sicher für Babyhaut?
- No infant‑specific reproductive or developmental toxicity data for Rh4 and no regulatory reproductive classification were identified, so hazard remains 0. Mechanistic score not increased because there is no infant‑specific mechanistic evidence. Exposure for baby skin is increased by +1 from adult (adult e=0 → baby e=1) because infant skin has higher permeability and surface‑area‑to‑weight; Rh4 is not demonstrated to be non‑absorbable. No data were found showing topical Rh4 causes adverse effects in infants 0–3 y.
- Wie bewertet VeriMom ginsenoside rh4?
- VeriMom bewertet ginsenoside rh4 mit 93/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu ginsenoside rh4?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu ginsenoside rh4 basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.